Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Clinical Gastroenterology and Hepatology - United Kingdom
doi 10.1016/j.cgh.2014.01.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-Making for IBD Outpatients on Maintenance Infliximab Therapy

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2015English

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

British Journal of Clinical Pharmacology
Pharmacology
2013English

PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

Gut
Gastroenterology
2013English

Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays

Therapeutic Advances in Gastroenterology
Gastroenterology
2016English

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: New Thresholds Need to Be Defined When Using Point of Care Assays to Monitor Infliximab Trough Levels in IBD Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Infliximab in Active Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy